{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:24:41Z","timestamp":1761744281208},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jvir.2016.02.032","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T23:02:08Z","timestamp":1463007728000},"page":"1086-1092","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect"],"prefix":"10.1016","volume":"27","author":[{"given":"Gyoung Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Deuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Yun","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Il","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonseon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minwoo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2016.02.032_bib1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2016.02.032_bib2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1440-1746.2007.04997.x","article-title":"Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma","volume":"22","author":"Wu","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2016.02.032_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/02841850801958890","article-title":"Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"49","author":"Wang","year":"2008","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jvir.2016.02.032_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00432-014-1713-4","article-title":"Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1alpha pathway in patients with hepatocellular carcinoma","volume":"140","author":"Xu","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jvir.2016.02.032_bib5","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jvir.2016.02.032_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2016.02.032_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2016.02.032_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jvir.2013.01.488","article-title":"Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model","volume":"24","author":"Gaba","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2016.02.032_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2013.08.007","article-title":"Transarterial embolization with sorafenib in animal livers: a pharmacokinetics study","volume":"24","author":"Chatziioannou","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2016.02.032_bib10","first-page":"7775","article-title":"Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jvir.2016.02.032_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5152\/dir.2014.14394","article-title":"Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model","volume":"21","author":"Parvinian","year":"2015","journal-title":"Diagn Interv Radiol (Ank)"},{"key":"10.1016\/j.jvir.2016.02.032_bib12","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1158\/1078-0432.CCR-12-0552","article-title":"Sorafenib inhibits hypoxia-inducible factor-1alpha synthesis: implications for antiangiogenic activity in hepatocellular carcinoma","volume":"18","author":"Liu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvir.2016.02.032_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/dna.2013.2184","article-title":"Sorafenib blocks the HIF-1alpha\/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells","volume":"33","author":"Xu","year":"2014","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.jvir.2016.02.032_bib14","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-11-2175","article-title":"Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvir.2016.02.032_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/cncr.28384","article-title":"Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma","volume":"120","author":"Tsuchiya","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2016.02.032_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00595-006-3196-7","article-title":"Liver injury in sepsis and abdominal compartment syndrome in rats","volume":"36","author":"Muftuoglu","year":"2006","journal-title":"Surg Today"},{"key":"10.1016\/j.jvir.2016.02.032_bib17","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.01.006","article-title":"Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma","volume":"56","author":"Park","year":"2012","journal-title":"J Hepatol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044316003833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044316003833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T03:58:06Z","timestamp":1536724686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044316003833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1051044316003833"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2016.02.032","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2016.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SIR. Published by SIR All rights reserved.","name":"copyright","label":"Copyright"}]}}